Waters Corporation to Present at the Jefferies Global Healthcare Conference

Waters (NYSE:WAT) announced that President and CEO Udit Batra, Ph.D., will join a fireside chat at the Jefferies Global Healthcare Conference on June 3, 2026, at 10:30 AM ET.

Rhea-AI Summary

Waters (NYSE:WAT) announced that President and CEO Udit Batra, Ph.D., will join a fireside chat at the Jefferies Global Healthcare Conference on June 3, 2026, at 10:30 AM ET.

A live webcast and 90-day replay will be available on Waters' investor relations site.

Argus May 19 session

+0.32% close to close Open Argus

Details

News Market Reaction – WAT

On May 19, the first trading day after this news, WAT closed 0.32% above the previous close.

Data tracked by StockTitan Argus for the May 19 session.

Market Context

This announcement highlights Waters’ participation in a major healthcare conference, offering anothe...

Analysis

This announcement highlights Waters’ participation in a major healthcare conference, offering another venue for management to articulate strategy and discuss recent developments, including Q1 2026 results of $1.267 billion in revenue and raised guidance. In context, investors may track how messaging around acquisitions, leverage, and new product launches evolves. Key watchpoints include execution on integration, regulatory milestones, and any future capital markets activity under the existing automatic shelf.

Key Figures

Conference date: June 3, 2026 Conference time: 10:30 AM ET Webcast replay period: 90 days +1 more

Conference date

June 3, 2026

Jefferies Global Healthcare Conference fireside chat

Conference time

10:30 AM ET

Scheduled time of Jefferies fireside chat

Webcast replay period

90 days

Replay availability on Waters’ Investor Relations website

Employees

approximately 16,000

Global workforce cited in company description

Historical Context

5 past events · Latest: May 05

5 events

1. May 05

   Earnings results

   24h Move

   +13.5%

   Q1 2026 beat guidance and guidance raised, lifting shares sharply.

2. Apr 20

   Earnings call setup

   24h Move

   -0.1%

   Scheduled Q1 2026 earnings call and webcast details for investors.

3. Apr 14

   Product launch

   24h Move

   +1.9%

   Introduced omniDAWN MALS detector with faster runs and lower sample use.

4. Apr 08

   FDA clearance

   24h Move

   +3.6%

   FDA cleared at‑home Onclarity HPV kit and approved HPV assay.

5. Mar 18

   Debt offering

   24h Move

   -0.7%

   Priced $3.5B senior notes for refinancing, increasing leverage modestly.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MILFORD, Mass., May 18, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D., Waters President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 3rd, 2026, at 10:30 AM Eastern Time.

A live webcast of the event will be available on the 'Events & Presentations' section of Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will be available for 90 days.

About Waters Corporation

Waters Corporation (NYSE:WAT) is a global leader in life sciences, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innovative portfolio harnesses deep scientific expertise across chemistry, physics, and biology. We collaborate with analytical laboratories around the world to advance the release of effective, high-quality medicines, assure the safety of food and water, and drive better patient outcomes by detecting diseases earlier, managing routine infections, and combatting growing antibiotic resistance. Through a shared culture of relentless innovation, our passionate team of approximately 16,000 employees partner with our customers to turn scientific challenges into breakthroughs that improve lives worldwide.

Caspar Tudor, Head of Investor Relations
investor_relations@waters.com

View original content:https://www.prnewswire.com/news-releases/waters-corporation-to-present-at-the-jefferies-global-healthcare-conference-302775033.html

SOURCE Waters Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Waters (NYSE:WAT) present at the Jefferies Global Healthcare Conference 2026?

Waters will present at the Jefferies Global Healthcare Conference on June 3, 2026, at 10:30 AM Eastern Time. According to Waters, President and CEO Udit Batra, Ph.D., will participate in a fireside chat during the event.

Who is representing Waters (WAT) at the June 3, 2026 Jefferies Global Healthcare Conference?

Waters will be represented by Udit Batra, Ph.D., its President and Chief Executive Officer. According to Waters, he will participate in a scheduled fireside chat, offering investors an opportunity to hear leadership perspectives on the company and its strategy.

How can investors access the Waters (WAT) webcast from the Jefferies Global Healthcare Conference 2026?

Investors can access a live webcast via the Events & Presentations section of Waters’ investor relations website. According to Waters, a replay of the webcast will remain available online for 90 days following the event.

How long will the replay of Waters (WAT) Jefferies Global Healthcare Conference 2026 presentation be available?

The replay of Waters’ Jefferies Global Healthcare Conference webcast will be available for 90 days. According to Waters, investors can find the replay in the Events & Presentations area of the company’s investor relations website after the live session.

What does Waters (WAT) do in the life sciences industry?

Waters is a global life sciences company focused on analytical technologies, informatics, and service. According to Waters, it supports regulated, high-volume testing labs worldwide, helping release medicines, ensure food and water safety, and improve patient outcomes through earlier disease detection.